John Glenn's Net Worth

$1.72 Million

Estimate Recalculated Apr 7, 2025 08:11PM EST

Who is John Glenn

John Glenn has an estimated net worth of $1.72 Million. This is based on reported shares across multiple companies, which include EKSO BIONICS HOLDINGS, INC., IRADIMED CORP, SOLTA MEDICAL INC, CHOLESTECH CORPORATION, and INVIVO CORP.

SEC CIK

John Glenn's CIK is 0001253497

Past Insider Trading and Trends

2022 was John Glenn's most active year for acquiring shares with 6 total transactions. John Glenn's most active month to acquire stocks was the month of January. 2004 was John Glenn's most active year for disposing of shares, totalling 8 transactions. John Glenn's most active month to dispose stocks was the month of December. 2022 saw John Glenn paying a total of $71,675.75 for 61,310.183 shares, this is the most they've acquired in one year. In 2014 John Glenn cashed out on 735,075 shares for a total of $1,551,825.48, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EKSO BIONICS HOLDINGS, INC.

Chief Financial Officer
Updated Mar 28, 2022
Form 4
-8.97%
-3.46K
$2.82
-$9.76K
Mar 28, 2022
35.13K
Sale
Mar 22
Form 4
60.83%
14.60K
Feb 22, 2022
38.59K
Grant
Feb 17
Form 4
118.52%
13.02K
Mar 05, 2021
24.00K
Grant
Mar 03
Form 4
3,397.13%
10.67K
Apr 02, 2020
10.98K
Grant
Apr 01
Form 4
60.00%
240.00K
Nov 08, 2019
640.00K
Grant
Nov 06
Form 4
-68.61%
-10.29K
$1.37
-$14.10K
Jun 19, 2019
4.71K
Sale
May 31
Form 4
15.00K
Apr 26, 2019
15.00K
Grant
Apr 24
Form 4
400.00K
Sep 04, 2018
400.00K
Grant
Aug 31
Form 3
Aug 22, 2018
Showing 9 results

IRADIMED CORP

CHIEF FINANCIAL OFFICER
Updated Apr 07, 2025
Form 4/A
-33.33%
-5.80K
Apr 07, 2025
11.59K
Options
Jun 20
Form 4
37.40%
14.36K
Dec 11, 2023
52.76K
Grant
Dec 07
Form 4
-5.50%
-1.41K
$47.88
-$67.61K
Jun 22, 2023
24.27K
Options
Jun 20
Form 4
2.50K
$28.67
$71.68K
Dec 16, 2022
2.50K
Grant
Dec 15
Form 4
90.62%
21.01K
Dec 09, 2022
44.19K
Grant
Dec 07
Form 4/A
23.18K
Jul 08, 2022
23.18K
Grant
Jun 20
Form 4
23.18
Jun 23, 2022
23.18
Grant
Jun 20
Form 3
Jun 22, 2022
Showing 8 results

SOLTA MEDICAL INC

Chief Financial Officer
Updated Jan 27, 2014
Form 4
-94.35%
-693.52K
$2.20
-$1.55M
Jan 27, 2014
41.56K
Options
Jan 23
Form 4
-7.48%
-53.54K
$2.56
-$137.07K
Feb 12, 2013
662.66K
Options
Feb 08 - Feb 10
Form 4
46.55%
168.80K
Feb 06, 2013
531.43K
Grant
Feb 04
Form 4
-5.64%
-21.40K
$2.99
-$63.99K
Feb 13, 2012
358.23K
Options
Feb 09 - Feb 10
Form 4
96.06%
186.00K
Feb 10, 2012
379.64K
Grant
Feb 08
Form 4
910.11%
170.40K
Feb 14, 2011
189.12K
Grant
Feb 10
Form 4
175.00K
Feb 10, 2010
175.00K
Grant
Feb 08
Form 4
-33.60%
-7.66K
$2.00
-$15.31K
Jan 26, 2010
15.13K
Tax
Jan 23
Form 4
139.00K
Mar 02, 2009
139.00K
Grant
Feb 27
Form 4
17.79K
Dec 24, 2008
17.79K
Grant
Dec 23
Form 4
175.00K
Feb 13, 2008
175.00K
Grant
Feb 11
Form 3
Jan 04, 2008
Showing 12 results

CHOLESTECH CORPORATION

CFO and V.P. Finance
Updated Sep 13, 2007
Form 4
-100.00%
-80.00K
Sep 13, 2007
Disposition
Sep 12
Form 4
-5.88%
-5.00K
$12.30
-$53.31K
Nov 17, 2006
80.00K
Sale
Nov 15
Form 4
20.00K
Mar 28, 2006
20.00K
Grant
Mar 22
Form 4
22.00K
Mar 25, 2005
22.00K
Grant
Mar 23
Form 4
50.00%
1.00K
$10.90
$10.90K
Mar 03, 2005
3.00K
Purchase
Mar 03
Form 4
2.00K
$8.01
$16.02K
Nov 09, 2004
2.00K
Purchase
Nov 08
Form 4
40.00K
Oct 14, 2004
40.00K
Grant
Oct 13
Form 3
Oct 14, 2004
Showing 8 results

INVIVO CORP

CFO
Updated Feb 04, 2004
Form 4
-100.00%
-132.00K
$14.95
-$1.94M
Feb 04, 2004
Disposition
Jan 30
Showing 1 results